510(k) DEN120012
DEN120012 is an FDA 510(k) premarket notification submitted by Centers for Disease Control and Prevention for the device "CDC DENV-1-4 REAL TIME RT-PCT ASSAY". The FDA issued a decision of De Novo Granted on May 24, 2012. The device falls under product code OZB (Dengue Nucleic Acid Amplification Assay (Naat)), a Class II device regulated under 21 CFR 866.3946. Centers for Disease Control and Prevention has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- DENG (De Novo Granted)
- Decision Date
- May 24, 2012
- Date Received
- March 12, 2012
- Clearance Type
- Post-NSE
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Dengue Nucleic Acid Amplification Assay (Naat)
- Device Class
- Class II
- Regulation Number
- 866.3946
- Review Panel
- MI
- Submission Type
A qualitative in vitro diagnostic assay for the detection of dengue virus serotypes 1, 2, 3 or 4 in serum or plasma specimens collected from human patients with signs and symptoms consistent with dengue (mild or severe).